Health Care & Life Sciences » Biotechnology | Chabiotech Co. Ltd.

Chabiotech Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
11,714
2,852
12,905
27,400
57,513
Depreciation, Depletion & Amortization
21,602
12,989
15,871
15,202
13,034
Other Funds
1,729
8,148
703
15,000
110,778
Funds from Operations
93,106
46,322
34,201
48,148
20,820
Changes in Working Capital
26,753
48,890
27,661
30,099
4,634
Net Operating Cash Flow
66,353
2,568
61,863
18,049
16,186
Capital Expenditures
42,467
55,501
31,357
34,129
41,987
Sale of Fixed Assets & Businesses
605
62
18
13
70
Purchase/Sale of Investments
88,022
64,658
18,107
89,852
23,097
Net Investing Cash Flow
129,355
10,898
50,539
128,626
65,442
Issuance/Reduction of Debt, Net
12,710
1,517
15,563
62,521
74,799
Net Financing Cash Flow
132,213
6,365
19,493
78,516
36,928
Net Change in Cash
69,189
14,653
34,883
30,401
22,685
Free Cash Flow
38,500
47,806
39,065
6,980
17,489
Net Assets from Acquisitions
105
-
226
116
-
Other Sources
6,771
2,449
13,306
1,962
3,648
Change in Capital Stock
117,775
266
4,632
995
949
Exchange Rate Effect
22
42
4,067
1,660
10,357
Other Uses
6,137
770
14,173
6,504
4,076

About Chabiotech Co.

View Profile
Address
3rd Floor, Pie'n Polus Building
Seoul SL 06062
Korea, Republic Of
Employees -
Website http://www.chabio.co.kr
Updated 09/14/2018
Cha Biotech Co., Ltd. engages in the research of cell therapy and storage of cord blood. It operates through the following business: Cell Therapy Development, Bio, Chaum, and Bio Insurance. The Cell Therapy Development business develops and commercializes cell therapy.